Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Why This Beaten-Down Medical Device Stock Could Be Your Best Investment for the Next 5 Years
Why This Beaten-Down Medical Device Stock Could Be Your Best Investment for the Next 5 Years

Medical device specialist DexCom (NASDAQ: DXCM) has encountered significant headwinds in the past year. The company's financial results haven't been quite up to the market's standards, and broader

Billionaire David Tepper Sold Nvidia and AMD and Is Piling Into This Specialized AI Chipmaker Instead
Billionaire David Tepper Sold Nvidia and AMD and Is Piling Into This Specialized AI Chipmaker Instead

David Tepper is one of the most successful investment managers on Wall Street. His Appaloosa Management hedge fund has produced gross annualized returns of more than 28% since its inception in 1993

Here's Why This $50 Healthcare Stock Could Be the Next $200 Winner
Here's Why This $50 Healthcare Stock Could Be the Next $200 Winner

A decade ago, shares of Exelixis (NASDAQ: EXEL), a biotech company specializing in oncology, were trading for under $10 per share. Today, the drugmaker's shares are changing hands for about $45

These 2 Stocks Could More Than Double Your Money, According to Wall Street. Is It Time to Buy?
These 2 Stocks Could More Than Double Your Money, According to Wall Street. Is It Time to Buy?

Investors seeking stocks that can put up dramatic gains in a short amount of time can find what they're looking for in the biotechnology industry. Investment bank analysts on Wall Street have tagged

After Falling 68%, Where Will This Weight-Loss Drug Stock Be in 2 Years? History Shows Massive Gains Ahead.
After Falling 68%, Where Will This Weight-Loss Drug Stock Be in 2 Years? History Shows Massive Gains Ahead.

Any investor who owned Viking Therapeutics (NASDAQ: VKTX) before November of last year is sure to be disappointed and maybe even a little worried. Shares are down nearly 60% since October last year

2 Reliable Dividend Stocks With Yields Above 6% That You Can Buy With $100 Right Now
2 Reliable Dividend Stocks With Yields Above 6% That You Can Buy With $100 Right Now

If putting your money to work on Wall Street is something you haven't started doing because it feels like a rich person's game and you're not one, I've got good news. Discount brokerages no longer

Abbott Reports 10.5% EPS Growth for Fiscal Q2
Abbott Reports 10.5% EPS Growth for Fiscal Q2

Abbott Laboratories (NYSE:ABT), a global healthcare company known for its medical devices, diagnostics, nutrition, and pharmaceuticals, reported fiscal 2025 earnings on Thursday, July 17, that

These Are 2 of the Worst-Performing Stocks in the S&P 500 in 2025
These Are 2 of the Worst-Performing Stocks in the S&P 500 in 2025

After briefly dipping into bear market territory just three months ago, the S&P 500 (SNPINDEX: ^GSPC) has quickly managed to recover, rising 6.6% year to date (as of this writing). But not all

Abbott (ABT) Q2 2025 Earnings Call Transcript
Abbott (ABT) Q2 2025 Earnings Call Transcript

Image source: The Motley Fool.

Need a quote from one of our analysts? Email [email protected]

Abbott Laboratories (NYSE:ABT) presented a quarter marked by distinct segment divergence, with medical devices

Ayrshire Dumps 11,424 UnitedHealth Group Shares in Full Exit
Ayrshire Dumps 11,424 UnitedHealth Group Shares in Full Exit

Ayrshire Capital Management LLC sold its position in UnitedHealth Group Incorporated(NYSE:UNH) during the quarter ended June 30, 2025, executing trades totaling $5.98 million.

According to a recent

Dexcom Unveils Season 4 Roster for Game-Changing NIL Program at Signing Day Camp Hosted by Mark Andrews
Dexcom Unveils Season 4 Roster for Game-Changing NIL Program at Signing Day Camp Hosted by Mark Andrews


DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the launch of the fourth season of Dexcom U, the company’s one-of-a-kind NIL (Name, Image and Likeness) program

Merck Just Announced a $10 Billion Deal That Will Help Diversify Its Business
Merck Just Announced a $10 Billion Deal That Will Help Diversify Its Business

One of the biggest concerns with healthcare giant Merck (NYSE: MRK) is its dependence on top-selling cancer drug Keytruda. While it has been a beast for the business over the years, generating

3 Growth Stocks That Could Help Make You a Fortune
3 Growth Stocks That Could Help Make You a Fortune

After a turbulent start to 2025, the stock market is once again near its all-time highs. The S&P 500, Nasdaq Composite, and Dow Jones Industrial Average are up 6%, 7%, and 4%, respectively, year to

EQS-News: Gerresheimer ends discussions with private equity investors about a potential takeover offer
EQS-News: Gerresheimer ends discussions with private equity investors about a potential takeover offer
EQS-News: Gerresheimer ends discussions with private equity investors about a potential takeover offer
EQS-Adhoc: Gerresheimer AG: Discussions on potential takeover offer ended
EQS-Adhoc: Gerresheimer AG: Discussions on potential takeover offer ended
EQS-Adhoc: Gerresheimer AG: Discussions on potential takeover offer ended
Is It Too Late to Buy AMD Stock?
Is It Too Late to Buy AMD Stock?

In this video, I will discuss the recent updates regarding Advanced Micro Devices (NASDAQ: AMD). Watch the short video to learn more, consider subscribing, and click the special offer link below.

This Once-Dominant Healthcare Stock Down 50% Is Finally Ready for a Comeback
This Once-Dominant Healthcare Stock Down 50% Is Finally Ready for a Comeback

A few years ago, Pfizer (NYSE: PFE) was on top of the world when it came to earnings and stock price performance. The pharma giant recorded a record of $100 billion in sales back in 2022, and saw

Stock Market Today: Nvidia Climbs on China GPU Export Resumption
Stock Market Today: Nvidia Climbs on China GPU Export Resumption

Nvidia (NASDAQ: NVDA) shares surged 4% to close at $170.70 on Tuesday, outpacing broader market indices as investors responded positively to news about graphics processing unit (GPU) exports to

Why AngioDynamics Stock Popped, Then Dropped Today
Why AngioDynamics Stock Popped, Then Dropped Today

Tuesday started off well for AngioDynamics (NASDAQ: ANGO), maker of such medical devices as the NanoKnife tool for "electrocuting" cancer, as well as multiple devices for treating peripheral

Why Taiwan Semiconductor Stock Was Climbing Today
Why Taiwan Semiconductor Stock Was Climbing Today

Shares of Taiwan Semiconductor Manufacturing (NYSE: TSM) were moving higher as the chip manufacturing giant seemed to benefit from a broader tailwind in the semiconductor industry after Nvidia said

Nvidia and AI Stock Investors Just Got Spectacular News From Meta Platforms
Nvidia and AI Stock Investors Just Got Spectacular News From Meta Platforms

In today's video, I discuss recent updates affecting Nvidia (NASDAQ: NVDA), Advanced Micro Devices (NASDAQ: AMD), and other semiconductor companies. To learn more, check out the short video,

Massive News for AMD and Nvidia Stock Investors
Massive News for AMD and Nvidia Stock Investors

In this video, I will discuss the recent updates regarding Nvidia, Meta, and Advanced Micro Devices (NASDAQ: AMD). Watch the short video to learn more, consider subscribing, and click the special

EQS-News: Gerresheimer Achieves A- Score in CDP Rating
EQS-News: Gerresheimer Achieves A- Score in CDP Rating
EQS-News: Gerresheimer Achieves A- Score in CDP Rating
This Artificial Intelligence (AI) Stock Is Underappreciated and Undervalued
This Artificial Intelligence (AI) Stock Is Underappreciated and Undervalued

Both the S&P 500 and Nasdaq Composite indexes are hovering around all-time highs. Unsurprisingly, a euphoric narrative surrounding all things touching artificial intelligence (AI) has helped fuel

Ferguson Wellman Dumps 155,436 UNH Shares in Q2
Ferguson Wellman Dumps 155,436 UNH Shares in Q2

According to a SEC filing dated July 10, Ferguson Wellman Capital Management sold 155,436 shares of UnitedHealth Group(NYSE:UNH) during the quarter ending June 30, 2025, with transactions totaling